Загрузка...
Why So Few Drugs for Alzheimer's Disease? Are Methods Failing Drugs?
Recent studies of Alzheimer's disease (AD) and other neuropsychiatric drug developments raise questions whether failures of some drugs occur due to flaws in methods. In three case studies of recent AD drug development failures with phenserine, metrifonate, and tarenflurbil we identified methodo...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3010269/ https://ncbi.nlm.nih.gov/pubmed/20704560 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|